<DOC>
	<DOC>NCT00825578</DOC>
	<brief_summary>Hypothesis: Patients with advanced emphysema with predominance of the disease in areas other than the upper lobes, as determined by high resolution computed tomography (HRCT), could have a positive response to valve treatment.</brief_summary>
	<brief_title>Use of Endobronchial Valves in Non-Upper Lobe Heterogeneous Emphysema</brief_title>
	<detailed_description />
	<mesh_term>Emphysema</mesh_term>
	<mesh_term>Pulmonary Emphysema</mesh_term>
	<criteria>Age 1880 years Exsmoker with smoking cessation confirmed by exhaled carbon monoxide (CO) levels Moderate to severe airflow obstruction FEV1 &lt;50% Predicted Severe dyspnoea mMRC ≥2 Hyperinflation total lung capacity (TLC) ≥100% predicted, RV ≥150% predicted SWT ≥75m Optimum COPD treatment for at least 6 weeks No COPD exacerbation for at least 6 weeks Less than 4 admissions for exacerbation in the preceding 12 months Patient unable to provide informed consent Patient without clear targets for airflow redistribution Total lung CO uptake (TLCO) &lt;15% predicted and FEV1 &lt;15% predicted pO2 on air &lt;6.0kPa pCO2 on air &gt;8.0kPa Neurological, rheumatological or other cause of exercise limitation Other major medical illness, e.g. lung cancer that will limit participation Production of purulent sputum more often than not (more than 50% of days) Clinically significant bronchiectasis Large bulla more than 1/3 of hemithorax volume (i.e. where bullectomy would be more suitable) on CT scan Arrhythmia or cardiovascular disease that poses a risk during procedure or exercise Prednisolone dose greater than 15mg a day Significant pulmonary hypertension RVSP ≥45mmHg Left ventricular failure left ventricular ejection fraction &lt;45% or left ventricular fraction shortening &lt;23% Prior LVRS or lobectomy Lung nodule requiring surgery Subject completed or is participating in a standard pulmonary rehabilitation program within 3 months of enrolment Female of childbearing age with positive pregnancy test Subject participated in a research study of investigational drug or device in prior 30 days Subject taking clopidogrel, warfarin, or other anticoagulants and unable to abstain for 5 days preprocedure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>intrabronchial valve</keyword>
	<keyword>heterogeneous emphysema</keyword>
	<keyword>non-upper lobe</keyword>
</DOC>